Erythrocyte glycohydrolases in subjects with trisomy 21: Could Down's syndrome be a model of accelerated ageing?

Mechanisms of Ageing and Development

Volumn 127, Issue 4, 2006, Pages 324-331

  Massaccesi, L ^a   Corsi, M M ^a   Baquero Herrera, C J ^a   Licastro, F ^b   Tringali, C ^a   Venerando, B ^a   Lombardo, A ^a   Alberghino, A ^c   Goi, Giancarlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Ageing; Down syndrome; Erythrocyte; Glycohydrolases; Oxidative stress

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; GLYCOSIDASE; HYDROPEROXIDE; N ACETYL BETA GLUCOSAMINIDASE;

ADULT; AGING; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOSOL; DISEASE MODEL; DOWN SYNDROME; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; ERYTHROCYTE; ERYTHROCYTE LIFESPAN; FEMALE; GROUPS BY AGE; HUMAN; HYDROLYSIS; MALE; MEMBRANE FLUIDITY; MOLECULAR MECHANICS; OXIDATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TRANSPORT; TRISOMY 21;

ADOLESCENT; ADULT; AGE FACTORS; AGING; ANISOTROPY; ANTIOXIDANTS; CASE-CONTROL STUDIES; CELL MEMBRANE; CHROMOSOMES, HUMAN, PAIR 21; CYTOSOL; DOWN SYNDROME; ERYTHROCYTE AGING; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FEMALE; GLYCOSIDE HYDROLASES; HEXOSAMINIDASES; HUMANS; HYDROLYSIS; KARYOTYPING; MALE; MEMBRANE FLUIDITY; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MODELS, BIOLOGICAL; N-ACETYLNEURAMINIC ACID; OXIDATIVE STRESS; OXYGEN; PEROXIDASES; TRISOMY;

EID: 33344470393     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2005.12.002     Document Type: Article

References (50)

1. B.N. Ames, M.K. Shigenaga, and T.M. Hagen Oxidants, antioxidants, and the generative diseases of aging Proc. Natl. Acad. Sci. U.S.A. 90 1993 7915 7922
2. P.A. Baird, and A.D. Sadovnick Causes of death to age 30 in Down syndrome Am. J. Hum. Genet. 43 1988 239 248
3. + pumping activity in erythrocytes from IDDM and NIDDM subjects Diabetes 38 1989 825 831
4. G. Bartosz, and J. Kedziora Aging of the erythrocyte. XX. Decreased red cell life span in Down's syndrome Cell Biol. Int. Rep. 6 1982 1119 1122
5. E. Beutler, K.G. Blume, J.C. Kaplan, J.W. Lhor, B. Ramot, and W.N. Valentine International Committee for standardisation in haematology: recommended methods for red-cell enzyme analysis Br. J. Haematol. 35 1977 331 335
6. G.J.C.G.M. Bosman, I.J.P. Bartholomeus, A.J.M. De Man, P.J.C. Van Kalmthout, and W.J. De Grip Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer's disease Neurobiol. Aging 12 1991 13 18
7. G.J.C.G.M. Bosman, F.E. Visser, A.J.M. De Man, I.J.P. Bartholomeus, and W.J. De Grip Erythrocyte membrane changes of individuals with Down's syndrome in various stages of Alzheimer-type dementia Neurobiol. Aging 14 1993 223 228
8. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
9. J. Busciglio, and B.A. Yankner Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro Nature 378 1995 776 779
10. L. Caimi, A. Lombardo, A. Preti, U. Wiesmann, and G. Tettamanti Optimal conditions for the assay of fibroblast neuraminidase with different natural substrates Biochim. Biophys. Acta 571 1979 137 145
11. M. Carratelli, L. Porcaro, M. Ruscia, E. De Simone, A.A.E. Bertelli, and M.M. Corsi Reactive oxygen metabolites and pro-oxidant status in children with Down's syndrome Int. J. Pharm. Res. 22 2001 79 84
12. R. Cazzola, S. Russo-Volpe, G. Cervato, and B. Cestaro Biochemical assessments of oxidative stress, erythrocyte membrane fluidity and antioxidant status in professional soccer players and sedentary controls Eur. J. Clin. Invest. 33 2003 924 930
13. G. Cervato, P. Viani, R. Cazzola, and B. Cestaro A fluorescent method for determination of plasma susceptibility to peroxidation Clin. Biochem. 32 1999 171 177
14. F.I. Comer, and G.W. Hart O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and O-phosphate J. Biol. Chem. 275 2000 29179 29182
15. J.B. De Haan, E.J. Wolvetang, F. Cristiano, R. Iannello, C. Bladier, M.J. Kelner, and I. Kola Reactive oxygen species and their contribution to pathology in Down's syndrome Adv. Pharmacol. 38 1997 379 402
16. D.L.Y. Dong, and G.W. Hart Purification and characterization of an O-GlcNAc selective N-acetyl-β-d-glucosaminidase from rat spleen cytosol J. Biol. Chem. 269 30 1994 19321 19330
17. J. Fehr, and M. Knob Comparison of red cell creatine level and reticulocyte count in appraising the severity of hemolytic processes Blood 53 5 1979 966 976
18. R. Gareau, H. Goulet, C. Chenard, C. Caron, and G.R. Brisson Fluorescent studies on aged and young erythrocyte populations Cell. Mol. Biol. 37 1 1991 15 19
19. G. Goi, C. Bairati, G. Segalini, A.B. Burlina, L. Massaccesi, A. Lovagnini, and A. Lombardo Alterations in the activity of several glycohydrolases in red blood cell membrane from type 2 diabetes mellitus patients Metab.: Clin. Exp. 48 1999 817 821
20. G. Goi, C. Bairati, L. Massaccesi, A. Lovagnini, A. Lombardo, and G. Tettamanti Membrane anchoring and surface distribution of glycohydrolases of human erythrocyte membranes FEBS Lett. 473 2000 89 94
21. G. Goi, R. Cazzola, C. Tringali, L. Massaccesi, S. Russo Volpe, M. Rondanelli, E. Ferrari, C.J. Baquero Herrera, B. Cestaro, A. Lombardo, and B. Venerando Erythrocyte membrane alterations during ageing affect β-d-glucuronidase and neutral sialidase in elderly healthy subjects Exp. Geront. 40 2005 219 225
22. L.S. Griffith, M. Mathes, and B. Schmitz Beta-amyloid precursor protein is modified with O-linked N-acetylglucosamine J. Neurosci. Res. 41 1995 270 278
23. G.D. Holt, R.S. Haltiwanger, C.R. Torres, and G.W. Hart Erythrocytes contain cytoplasmic glycoproteins O-linked GlcNAc on Band 4.1 J. Biol. Chem. 262 1987 14847 14850
24. R. Jayakumar, J.W. Kusiak, F.J. Chrest, A.A. Demehin, J. Murali, R.P. Wersto, E. Nagababu, L. Ravi, and J.M. Rikkind Red cell perturbations by amyloid beta-protein Biochim. Biophys. Acta 1622 1 2003 20 28
25. C. Jeandel, M.B. Nicolas, F. Dubois, F. Nabet-Belleville, F. Penin, and G. Cuny Lipid peroxidation and free radical scavengers in Alzheimer's disease Gerontology 35 1989 275 282
26. A. Kantar, P.L. Giorgi, G. Curatola, and R. Fiorini Alteration in erythrocyte membrane fluidity in children with trisomy 21: a fluorescence study Biol. Cell 75 1992 135 138
27. F. Licastro, M. Chiappelli, M. Ruscica, V. Carnelli, and M.M. Corsi Altered cytokine and acute phase response protein levels in the blood of children with Down syndrome: relationship with dementia of Alzheimer's type Int. J. Immunopathol. Pharmacol. 18 2005 165 172
28. A. Lombardo, L. Caimi, S. Marchesini, G. Goi, and G. Tettamanti Enzymes of lysosomal origin in human plasma and serum: assay conditions and parameters influencing the assay Clin. Chim. Acta 108 1980 337 346
29. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the folin phenol reagent J. Biol. Chem. 193 1951 265 275
30. M. Maggiora, M.U. Dianzani, and M.A. Rossi Effect of 4-hydroxynonenal, a lipid peroxidation product, on exocytosis in HL-60 cells Cell. Biochem. Funct. 20 2002 303 307
31. D.M. Mann, and M.M. Esiri The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome J. Neurol. Sci. 89 1989 169 179
32. G. Marra, P. Cotroneo, D. Pitocco, A. Manto, M.A.S. Di Leo, V. Ruotolo, S. Caputo, B. Giardina, G. Ghirlanda, and S.A. Santini Early increase of oxidative stress and reduced antioxidant defences in patients with uncomplicated type 1 diabetes Diab. Care 25 2002 370 375
33. L. Mazzanti, R.A. Rabini, E. Petruzzi, R. Staffaloni, E. Salvolini, A. Virgini, M. Barconi, and C. Franceschi Erythrocyte plasma membranes obtained from centenarians show different functional properties J. Am. Ger. Soc. 48 2000 350 351
34. A. Mosca, R. Paleari, A. Modenese, S. Rossini, R. Parma, C. Rocco, V. Russo, G. Caramenti, M.L. Paderi, and R. Galanello Clinical utility of fractionating erythrocytes into "Percoll" density gradients Adv. Exp. Med. Biol. 307 1991 227 238
35. P. Odetti, G. Angelici, D. Dapino, D. Zaccheo, S. Garibaldi, F. Dagna-Bricarelli, G. Piombo, G. Perry, M. Smith, N. Traverso, and M. Tabaton Early glycoxidation damage in brains from Down's syndrome Biochem. Biophys. Res. Commun. 243 1998 849 851
36. R.A. Rabibi, P. Fumelli, R. Staffolani, L. Mazzanti, A. Pugnaloni, G. Biagini, E. Faloia, and R. De Pirro Effects of diabetes mellitus on structural and functional properties of erythrocyte membranes Membr. Biochem. 10 1993 71 79
37. G. Salvo, P. Caprai, P. Samoggia, G. Marini, and A.M. Salvati Human erythrocyte separation according to age on a discontinuous "Percoll" density gradient Clin. Chim. Acta 122 1982 293 300
38. R. Seidl, S. Greber, E. Schuller, G. Bernett, N. Cairns, and G. Lubec Evidence against increased oxidative DNA-damage in Down brain Neurosci. Lett. 235 1997 137 140
39. J.L. Sever, M.R. Gilkeson, T.C. Chen, A.C. Ley, and D. Edmonds Epidemiology of mongolism in the Collaborative Project Ann. N. Y. Acad. Sci. 171 1970 328 330
40. P.M. Sinet Metabolism of oxygen derivatives in Down's syndrome Ann. N. Y. Acad. Sci. 396 1982 83 94
41. T.L. Steck, and J.A. Kant Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes Methods Enzymol. 31 1974 172 180
42. M.D. Stringer, P. Gorog, A. Freeman, and V.V. Kakkar Lipoid peroxides and atherosclerosis Br. Med. J. 298 1989 281 284
43. B. Venerando, A. Fiorilli, G.L. Croci, and G. Tettamanti Presence in human erythrocyte membranes of a novel form of sialidase acting optimally at neutral pH Blood 90 1997 2047 20256
44. B. Venerando, A. Fiorilli, G. Croci, C. Tringali, G. Goi, L. Mazzanti, G. Curatola, G. Segalini, L. Massaccesi, A. Lombardo, and G. Tettamanti Acidic and neutral sialidase in the erythrocyte membrane of type 2 diabetic patients Blood 99 2002 1064 1070
45. B. Venerando, G. Goi, L. Massaccesi, and A. Lombardo N-acetyl-β-d- glucosaminidase isoenzymes in membrane and cytosol of human erythrocytes Proceedings of the XVII International Symposium on Glycoconjugates 12-16 January 2003, Bangalore, India 2003
46. R.L. Walford, T.C. Gosset, and F. Naeim Immunological and biochemical studies of Down's syndrome as a model of accelerated aging D. Segre L. Smith Immunological Aspects of Aging 1981 Marcel Dekker, Inc. New York 479 532
47. K. Wisniewski, H.M. Wisniewski, and G.Y. Wen Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome Ann. Neurol. 17 1985 278 282
48. S. Yalcin, G. Haklar, and K. Emerk A simple colorimetric method for determination of peroxide Clin. Chem. 39 1993 2534 2535
49. P.J. Yao, and P.D. Coleman Reduction of O-linked N-acetylglucosamine- modified assembly protein-3 in Alzheimer's disease J. Neurosci. 18 1998 2399 2411
50. H. Yki-Jarvinen, A. Virkamaki, M.C. Daniels, D. McClain, and W.K. Gottschalk Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo Metabolism 47 1998 449 455